Accident – Death – Obituary News :
Discovery of Milk Peptide’s Anti-Inflammatory Properties in a Biotechnology Laboratory in the UK
Body-wide inflammation has long been associated with various chronic diseases that impact health and longevity. Recent data from a cutting-edge biotechnology laboratory in the UK has shed light on the potential of milk protein hydrolysate as a source of novel bioactive peptides. These peptides show promise in addressing inflammaging and age-related metabolic disorders.
Controversy Surrounding Milk Consumption and Health Implications
Over the years, there has been ongoing debate regarding the health benefits of milk consumption. While some researchers argue that it may not be essential for most adults and could even be harmful if consumed excessively, others have highlighted the positive metabolic effects of milk protein hydrolysates. These effects include improved glycemic control, enhanced glucose utilization, and optimized lipid metabolism.
Lactocore Group’s Innovative Approach
Lactocore Group, a biotech company based in the UK, founded by Dr. Anton Malyshev, focuses on isolating and enhancing the beneficial components of milk, particularly regulatory peptides. One of their key drug candidates, CHM-273S, has shown promising results in reducing weight and appetite, as well as normalizing glucose metabolism. A recent scientific article published in Pharmaceutics highlighted the potential of CHM-273S in alleviating glucose intolerance, insulin resistance, and systemic inflammation.
Understanding Inflammaging and Its Impact on Health
Inflammaging is a state of chronic inflammation that occurs with age in mammals, leading to various age-related illnesses such as diabetes, cancer, and Alzheimer’s disease. Dr. Malyshev explained that the immune system’s inability to regulate its response to illness or injury contributes to inflammaging. This chronic inflammation can have detrimental effects on overall health and longevity.
Promising Results in Extending Healthy Lifespan
Studies conducted by Lactocore Group using fish models have shown promising results in extending healthy lifespan. By introducing their milk peptides to killifish models, researchers observed a significant increase in life expectancy compared to control groups. These findings offer valuable insights into the potential of milk peptides in prolonging healthy life.
The Future of Longevity Research
With the global longevity sector projected to reach significant heights by 2025, there is a growing need for innovative solutions that enhance quality of life in later years. Milk-derived peptides, with their dual role in targeting inflammation and metabolic dysregulation, are poised to revolutionize the field of longevity research. Lactocore Group’s ongoing efforts to secure funding for further research and clinical studies highlight their commitment to advancing healthcare solutions.
Journal Reference:
Mitkin, N. A., et al. (2022) The novel peptide Chm-273s has therapeutic potential for metabolic disorders: Evidence from In vitro studies and high-sucrose diet and high-fat diet rodent models. Pharmaceutics doi.org/10.3390/pharmaceutics14102088
About Lactocore Group
Lactocore Group is a pioneering biotech startup based in the UK, dedicated to researching milk peptides for therapeutic applications. Their mission is to develop safe and effective treatments for common health issues affecting both humans and animals. With a focus on innovation and scientific discovery, Lactocore Group is at the forefront of advancing healthcare solutions for a healthier future.
.